CUMBERLAND PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.5 USD | -4.46% |
|
-10.18% | -16.28% |
| May. 07 | Transcript : Cumberland Pharmaceuticals Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| May. 07 | Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q1 Revenue $8.5M | MT |
Presentation Operator MessageOperator (Operator)Thanks to everyone participating on today's ca...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.
Sector
Pharmaceuticals
Calendar
2024-08-05
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -16.28% | 22.26M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.07% | 5.52B |
- Stock Market
- Equities
- CPIX Stock
- News Cumberland Pharmaceuticals Inc.
- Transcript : Cumberland Pharmaceuticals Inc., Q2 2020 Earnings Call, Aug 11, 2020
